Fourth quarter total revenue of $18.9 million, up 12% year-over-year Q4 adjusted EBITDA (1) of $0.9 million, up 18% year-over-year, and our 24 th consecutive quarter of positive adjusted EBITDA. Full year adjusted EBITDA up 19% year-over-year Positive cash flows, with significant investments in our facilities to support future growth In Q1 2025 performed the first-ever injection in North America of Arthrosamid ® (2.5% iPAAG)... Read More

$13.5 million package, including $7.0 million to accelerate growth via acquisition and working capital flexibility, and a $6.5 million term loan to consolidate existing debt NeuPath’s strong balance sheet and increasing cash flow attracted highly competitive bids from banks and top-tier lenders TORONTO / Mar 27, 2025 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“ NeuPath ” or the “ Company ”), owner and operator of a... Read More

Arthrosamid can provide pain relief for knee osteoarthritis patients for up to four years after a single procedure NeuPath continues to accelerate growth as it rolls out Arthrosamid across its clinic network Empowers NeuPath healthcare physicians to deliver innovative, best-in-class treatment to Canadians TORONTO / Mar 06, 2025 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and... Read More

TORONTO / Dec 10, 2024 / Business Wire / NeuPath Health Inc . (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the grant of stock options (“Options”) and restricted share units (“RSUs”). All figures are in Canadian dollars, unless otherwise noted. Issuance of Stock Options and Restricted Share Units On December 9, 2024,... Read More

TORONTO / Nov 27, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH) ( NeuPath or the “ Company ”) announced today that the TSX Venture Exchange (the “ Exchange ”) has accepted a notice filed by NeuPath of its intention to make a Normal Course Issuer Bid (“ NCIB ”) to be transacted through the facilities of the Exchange. Pursuant to the NCIB, the Company may, during the 12-month period commencing November 27, 2024 and... Read More

Third quarter total revenue of $17.6 million, up 9% year-over-year Adjusted EBITDA (1) of $0.7 million, up 9% year-over-year, and our 23 rd consecutive quarter of positive adjusted EBITDA Positive cash flow, with net debt down 8% versus September 30, 2023, and with significant investments in our facilities to support future growth TORONTO / Nov 14, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the... Read More

NeuPath to report Q3 2024 results on November 14 th before market open TORONTO / Oct 21, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), is pleased to invite investors and other interested parties to attend an upcoming interview with Market Radius Research. NeuPath’s Chief Executive Officer, Joe Walewicz intends to discuss NeuPath's untapped opportunities for growth as it expands to... Read More

Delivered record second quarter total revenue of $18.9 million, up 11% year-over-year Adjusted EBITDA (1) of $1.3 million, our 22 nd consecutive quarter of positive adjusted EBITDA Improved cash flows, with net debt down 37% versus June 30, 2023 TORONTO / Aug 15, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic... Read More

TORONTO / Jun 13, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 12, 2024. All figures are in Canadian dollars, unless otherwise noted. The results of the director... Read More

Delivered record first quarter total revenue of $17.5 million, up 9% year-over-year Adjusted EBITDA (1) of $0.9 million, our 21 st consecutive quarter of positive adjusted EBITDA Improved cash flows, closing cash and cash equivalents balance of $2.6 million, up more than 300% year-over-year TORONTO / May 16, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network... Read More

TORONTO / Apr 10, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2024 Bloom Burton & Co. Healthcare Investor Conference to be held April 16 to 17, 2024 at the Metro Toronto Convention Centre. NeuPath Presentation Date:... Read More

Fourth quarter total revenue of $16.8 million, up 4% year-over-year Adjusted EBITDA (1) of $0.8 million, our 20 th consecutive quarter of positive adjusted EBITDA Improved cash flows, closing cash and cash equivalents balance of $3.2 million, up more than 100% year-over-year Closed the acquisition of the assets of SIBI Medical Inc., operating as the London Spine Centre in London, Ontario TORONTO / Mar 15, 2024 / Business... Read More

Acquired the assets of SIBI Medical Inc., operating as the London Spine Institute, adding back, neck and spine specialists to enhance our care options for patients Located in, and adds to, our presence in London, Ontario TORONTO / Jan 15, 2024 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today... Read More

Third quarter total revenue of $16.1 million, up 6% year-over-year Adjusted EBITDA (1) of $0.7 million, our 19 th consecutive quarter of positive adjusted EBITDA and significantly improved year-over-year Positive cash flow and profitability in the quarter and year-to-date Improved future cash flows and access to new capital through recent closing of updated credit facility TORONTO / Nov 16, 2023 / Business Wire / NeuPath... Read More

Credit Facility provides immediate access to a new $3.5 million revolving credit facility Strengthened balance sheet and borrowing capacity to support accelerated growth strategy Improved cash flows resulting from re-financing of existing HealthPointe term debt TORONTO / Nov 13, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering... Read More

Completed the sale of its corporate-owned medical facility in London, Ontario for $2.1 million Repaid outstanding $1.2 million mortgage, expected net proceeds of more than $0.5 million Completed a successful move in July to a newer facility to better serve our patients Improved cash flows resulting from annualized operating savings TORONTO / Sep 05, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the... Read More

Delivered record second quarter total revenue of $17.1 million Adjusted EBITDA (1) of $1.0 million, our 18 th consecutive quarter of positive adjusted EBITDA, which improved significantly year-over-year Net profitable quarter with positive cash flow Substantially improved balance sheet to support our accelerated growth strategy TORONTO / Aug 17, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the... Read More

TORONTO / Jun 15, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced the voting results from its Annual General and Special Meeting of Shareholders (the “Meeting”) held on June 14, 2023 and the grant of stock options (“Options”) and restricted share units (“RSUs”). All figures are... Read More

Delivered first quarter revenue of $16.1 million, up 4.2% year over year Adjusted EBITDA (1) of $0.7 million, our 17 th consecutive quarter of positive adjusted EBITDA Continued focus on operational improvements and new services to better serve our patients TORONTO / May 25, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering... Read More

Received a positive response from the Canada Revenue Agency (the “CRA”) to our Notices of Objection regarding the Harmonized Sales Tax (“HST”) matter previously disclosed in our financial statements The CRA has provided updated Notices of Reassessment and will issue refunds totalling approximately $1.9 million to the Company TORONTO / May 15, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the... Read More

TORONTO / May 02, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“ NeuPath ” or the “ Company ”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced it has closed its previously announced brokered private placement offering of 10% subordinated and postponed unsecured non-convertible debenture units of the Company (the “ Units ”) for gross proceeds of... Read More

TORONTO / Apr 18, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced that Joseph Walewicz, CEO, will be presenting at the 2023 Bloom Burton & Co. Healthcare Investor Conference. Date: Wednesday, April 26, 2023 Time: 4:00 p.m. ET Format: 30-minute live virtual presentation,... Read More

TORONTO / Apr 11, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“ NeuPath ” or the “ Company ”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced a proposed offering of up to 1,400 units of the Company (the “ Units ”) pursuant to which NeuPath proposes to raise gross proceeds of up to $1.4 million (the “ Offering ”). The Offering is being led by Bloom... Read More

Delivered record fourth quarter revenues of $16.1 million Adjusted EBITDA (1) of $0.8 million, our 16 th consecutive quarter of positive adjusted EBITDA Recent clinic openings and expanded service offering to drive further momentum, continued focus on operational improvements to better serve our patients TORONTO / Mar 30, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator... Read More

TORONTO / Mar 21, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, is pleased to provide an update with selected preliminary unaudited results for the fourth quarter of 2022 and the full year ended December 31, 2022. The Company plans to release its audited fiscal 2022 financial results before... Read More

TORONTO / Mar 15, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an update on its ongoing focus on operational and balance sheet improvements. The Company has accepted a binding offer to purchase its corporate-owned medical facility in London, Ontario, with a closing date of... Read More

TORONTO / Mar 09, 2023 / Business Wire / NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today provided an open letter to shareholders from NeuPath’s CEO Joe Walewicz. The letter to shareholders is reproduced below. Dear Fellow Shareholders, One in four Canadians suffer from chronic pain. Many of you likely suffer... Read More